Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enoxaparin for thromboprophylaxis in hospitalized COVID‐19 patients: The X‐COVID‐19 Randomized Trial
Nuccia Morici, Gian Marco Podda, Simone Birocchi, et al.
European Journal of Clinical Investigation (2021) Vol. 52, Iss. 5
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

ISTH guidelines for antithrombotic treatment in COVID‐19
Sam Schulman, Michelle Sholzberg, Alex C. Spyropoulos, et al.
Journal of Thrombosis and Haemostasis (2022) Vol. 20, Iss. 10, pp. 2214-2225
Open Access | Times Cited: 145
2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
Sam Schulman, Donald M. Arnold, Charlotte Bradbury, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 6, pp. 1779-1797
Open Access | Times Cited: 18
Clinical features of thrombosis and bleeding in COVID-19
Mari R. Thomas, Marie Scully
Blood (2022) Vol. 140, Iss. 3, pp. 184-195
Open Access | Times Cited: 41
Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
COVID-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment
Luis Ortega‐Paz, Azita H. Talasaz, Parham Sadeghipour, et al.
Seminars in Thrombosis and Hemostasis (2022) Vol. 49, Iss. 08, pp. 816-832
Open Access | Times Cited: 28
Predictors of venous thromboembolic events in hospitalized patients with COVID-19
Giovanni Scimeca, Darsiya Krishnathasan, Sina Rashedi, et al.
Journal of Thrombosis and Thrombolysis (2025)
Closed Access
Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID‐19: The Swiss COVID‐HEP randomized clinical trial
Marc Blondon, Sara Cereghetti, Jérôme Pugin, et al.
Research and Practice in Thrombosis and Haemostasis (2022) Vol. 6, Iss. 4, pp. e12712-e12712
Open Access | Times Cited: 25
Anticoagulation in COVID-19 patients – An updated systematic review and meta-analysis
Stefanie Reis, Maria Popp, Selina Schießer, et al.
Thrombosis Research (2022) Vol. 219, pp. 40-48
Open Access | Times Cited: 20
COVID‐19 coagulopathy – what should we treat?
Pratima Chowdary
Experimental Physiology (2022) Vol. 107, Iss. 7, pp. 749-758
Open Access | Times Cited: 19
Practical Recommendations for Optimal Thromboprophylaxis in Patients with COVID-19: A Consensus Statement Based on Available Clinical Trials
Konstantinos G. Kyriakoulis, Evangelos Dimakakos, Ioannis Kyriakoulis, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 20, pp. 5997-5997
Open Access | Times Cited: 19
The Effect of Heparin Full-Dose Anticoagulation on Survival of Hospitalized, Non-critically Ill COVID-19 Patients: A Meta-analysis of High Quality Studies
Eros Pilia, Alessandro Belletti, Stefano Fresilli, et al.
Lung (2023) Vol. 201, Iss. 2, pp. 135-147
Open Access | Times Cited: 10
Anticoagulation in COVID-19 patients – An updated systematic review and meta-analysis
Stefanie Reis, Amon Faske, Ina Monsef, et al.
Thrombosis Research (2024) Vol. 238, pp. 141-150
Open Access | Times Cited: 3
The Role of Heparin in COVID-19: An Update after Two Years of Pandemics
Marco Mangiafico, Andrea Caff, Luca Costanzo
Journal of Clinical Medicine (2022) Vol. 11, Iss. 11, pp. 3099-3099
Open Access | Times Cited: 15
Advances and current research in primary thromboprophylaxis to prevent hospital‐associated venous thromboembolism
Lara N. Roberts, Roopen Arya, Beverley J. Hunt
British Journal of Haematology (2024) Vol. 204, Iss. 5, pp. 1635-1648
Closed Access | Times Cited: 2
Anticoagulation as secondary prevention of massive lung thromboses in hospitalized patients with COVID-19
Rosaria Sofia, Mattias Carbone, Giovanni Landoni, et al.
European Journal of Internal Medicine (2022) Vol. 100, pp. 21-24
Open Access | Times Cited: 11
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease—Preliminary Data
Filippo Biamonte, Agnese Re, Bijorn Omar Balzamino, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 11, pp. 1877-1877
Open Access | Times Cited: 11
Risk Factors of Venous Thromboembolism in Noncritically Ill Patients Hospitalized for Acute COVID-19 Pneumonia Receiving Prophylactic-Dose Anticoagulation
Francesco Poletto, Luca Spiezia, Chiara Simion, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 737-737
Open Access | Times Cited: 9
Evaluation of a fast‐and‐frugal clinical decision algorithm (‘pathways’) on clinical outcomes in hospitalised patients with COVID‐19 treated with anticoagulants
Benjamin Djulbegović, Iztok Hozo, David Lizarraga, et al.
Journal of Evaluation in Clinical Practice (2022) Vol. 29, Iss. 1, pp. 3-12
Open Access | Times Cited: 9
Anticoagulation Among Patients Hospitalized for COVID-19
Claire L. Vale, Peter J. Godolphin, David J. Fisher, et al.
Annals of Internal Medicine (2024)
Closed Access | Times Cited: 1
Prognostic Significance of the Coagulation and Complement Systems in Critical COVID-19 Infection
Amitabha Ray, Kristen A. K. Winter, Dayalu S. L. Naik, et al.
Prague Medical Report (2023) Vol. 124, Iss. 2, pp. 77-93
Open Access | Times Cited: 3
Endothelium dysfunction and thrombosis in COVID-19 with type 2 diabetes
Mengdi Li, Xiaoming Wu, Jialan Shi, et al.
Endocrine (2023) Vol. 82, Iss. 1, pp. 15-27
Closed Access | Times Cited: 3
Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: a systematic review with an updated meta-analysis
Hong Duo, Yahui Li, Yujie Sun, et al.
Thrombosis Journal (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 5
Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis
Awatif Hafiz, Hadeel Alkofide, Khalid Al Sulaiman, et al.
Clinical and Applied Thrombosis/Hemostasis (2023) Vol. 29
Open Access | Times Cited: 2
Intermediate dose enoxaparin in hospitalized patients with moderate-severe COVID-19: a pilot phase II single-arm study, INHIXACOVID19
Benilde Cosmi, Maddalena Giannella, G Fornaro, et al.
BMC Infectious Diseases (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 2
Thrombosis and coagulopathy in COVID-19: A current narrative
Alejandro Lazo‐Langner, Mateo Porres‐Aguilar
Elsevier eBooks (2024), pp. 337-348
Closed Access
Page 1 - Next Page

Scroll to top